AR114260A2 - SALTS AND POLYMORPHES OF A TETRACICLINE COMPOUND - Google Patents

SALTS AND POLYMORPHES OF A TETRACICLINE COMPOUND

Info

Publication number
AR114260A2
AR114260A2 ARP190100419A ARP190100419A AR114260A2 AR 114260 A2 AR114260 A2 AR 114260A2 AR P190100419 A ARP190100419 A AR P190100419A AR P190100419 A ARP190100419 A AR P190100419A AR 114260 A2 AR114260 A2 AR 114260A2
Authority
AR
Argentina
Prior art keywords
compound
salts
tetracicline
polymorphes
crystalline
Prior art date
Application number
ARP190100419A
Other languages
Spanish (es)
Inventor
Tadeusz Warchol
Raymond Cvetovich
Original Assignee
Paratek Pharm Innc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paratek Pharm Innc filed Critical Paratek Pharm Innc
Priority to ARP190100419A priority Critical patent/AR114260A2/en
Publication of AR114260A2 publication Critical patent/AR114260A2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proveen aquí formas cristalinas, incluyendo sales y polimorfos, de un compuesto útil para el tratamiento de estados que responden al compuesto de tetraciclina. Los compuestos cristalinos son útiles para el tratamiento o prevención de estados y trastornos como por ejemplo, infecciones bacterianas o neoplasmos, así como también otras aplicaciones para los compuestos de tetraciclina en general. Reivindicación 1: Una forma cristalina del compuesto de fórmula (1).Provided herein are crystalline forms, including salts and polymorphs, of a compound useful for treating conditions responsive to the tetracycline compound. The crystalline compounds are useful for the treatment or prevention of conditions and disorders such as, for example, bacterial infections or neoplasms, as well as other applications for tetracycline compounds in general. Claim 1: A crystalline form of the compound of formula (1).

ARP190100419A 2019-02-19 2019-02-19 SALTS AND POLYMORPHES OF A TETRACICLINE COMPOUND AR114260A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP190100419A AR114260A2 (en) 2019-02-19 2019-02-19 SALTS AND POLYMORPHES OF A TETRACICLINE COMPOUND

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP190100419A AR114260A2 (en) 2019-02-19 2019-02-19 SALTS AND POLYMORPHES OF A TETRACICLINE COMPOUND

Publications (1)

Publication Number Publication Date
AR114260A2 true AR114260A2 (en) 2020-08-12

Family

ID=72291183

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190100419A AR114260A2 (en) 2019-02-19 2019-02-19 SALTS AND POLYMORPHES OF A TETRACICLINE COMPOUND

Country Status (1)

Country Link
AR (1) AR114260A2 (en)

Similar Documents

Publication Publication Date Title
ECSP10010704A (en) SALTS AND POLYMORPHES OF A TETRATICLINE COMPOUND
CL2020002277A1 (en) Crystalline forms of triazolopyrimidine compound (divisional 201803734)
ECSP17026210A (en) SUBSTITUTE AMINOPURINE COMPOSITIONS, COMPOSITIONS OF THE SAME, AND TREATMENT METHODS THEREOF
UY37272A (en) PIRIDINES REPLACED WITH HETEROARILO AND METHODS OF USE
CU24411B1 (en) COMPOSITE DERIVED FROM BENZAMIDE REPLACED WITH 1,3-TIAZOL-2-ILO USEFUL FOR THE TREATMENT OF NEUROGENIC DISORDERS
DOP2021000234A (en) CONDENSED TRICYCLIC PYROLES AS MODULATORS OF ALPHA-1 ANTITRYPSIN
DOP2016000017A (en) NEW TRICYCLIC COMPOUNDS
ECSP20035590A (en) OXY-FLUOROPIPERIDINE DERIVATIVE AS A KINASE INHIBITOR
ECSP109919A (en) CRYSTAL PIRIDACINE COMPOUND
CU20210035A7 (en) AZALACTAM COMPOUNDS AS HPK 1 INHIBITORS
CO2019005534A2 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
DOP2021000017A (en) PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO PREVENT OR TREAT CANCERS INCLUDING THE SAME
CL2017002745A1 (en) New compounds and derivatives of sulfonimidoylpurinone for the treatment and prophylaxis of viral infections
CL2020001147A1 (en) Antibacterial compounds
DOP2016000308A (en) COMPOUNDS OF 1, 3, 4-TIADIAZOL AND USE OF THE SAME FOR THE TREATMENT OF CANCER
AR085308A1 (en) SOLID FORMS OF THE GIRASA INHIBITOR (R) -1-ETIL-3- [6-FLUORO-5- [2- (1-HIDROXI-1-METHYL-ETIL) PIRIMIDIN-5-IL] -7- (TETRAHIDROFURAN-2 -IL) -1H-BENZIMIDAZOL-2-IL] UREA
CL2020002157A1 (en) Triazine derivatives for the treatment of neurotrophin-related diseases.
MX2020004930A (en) Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors.
ECSP21011232A (en) NEW HETEROCYCLIC AMINE DERIVATIVE AND COMPOSITION OF THE PHARMACEUTICAL COMPOSITION
AR125457A2 (en) DUAL MAGL AND FAAH INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITION
CL2020002139A1 (en) 7-substituted sulfonimidoylpurinone compounds and their derivatives for the treatment and prevention of liver cancer.
CO2024001256A2 (en) Novel plk1 degradation-inducing compound
ECSP23088732A (en) TREX1 MODULATORS
CL2021000729A1 (en) Indane derivatives for use in the treatment of bacterial infection
CO2019007836A2 (en) Pyrrolotriazine derivatives as a kinase inhibitor